Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 8/20 | 0.73 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.73 |
| ▸ | HTR2B | P41595 | 1/20 | 0.73 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.63 |
| ▸ | AR | P10275 | 7/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | NR3C1 | P04150 | 9/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diflucortolone 21-Valerate SCHEMBL2790985 | 1.00 | PGR (0.73) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL3015 | 1.00 | PGR (0.73) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL1021717 | 1.00 | PGR (0.73) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL11243011 | 1.00 | PGR (0.73) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL9388448 | 1.00 | PGR (0.73) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL13157 | 1.00 | PGR (0.73) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL18113135 | 0.99 | PGR (0.72) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL2353254 | 0.99 | PGR (0.72) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL4454848 | 0.99 | PGR (0.72) | PGRNR1I2HTR2BHIF1AAR | |
| Diflucortolone 21-Valerate SCHEMBL20571795 | 0.99 | PGR (0.72) | PGRNR1I2HTR2BHIF1AAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5553 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4744657-A1 | THERAPEUTIC AGENT FOR HUMAN GRAFT VERSUS HOST DISEASE AND COMBINATION THEREOF | National University Corporation Okayama University (JP) | 2026-05-20 | — | — | EP | claimed |
| US-20260103492-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2026-04-16 | — | — | US | claimed |
| US-12421281-B2 | Cyclosporine compositions and methods of use | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2025-09-23 | — | — | US | claimed |
| US-20250288585-A1 | SYNERGISTIC COMPOSITIONS FOR ENHANCED HAIR GROWTH AND METHODS FOR TREATING HAIR LOSS | THE JOHNS HOPKINS UNIVERSITY | 2025-09-18 | — | — | US | claimed |
| EP-4598506-A1 | USE OF LONG-ACTING FLUTICASONE PROPIONATE INJECTABLE SUSPENSIONS FOR TREATING AND PREVENTING INFLAMMATIONS OF THE GASTROINTESTINAL TRACT | Eupraxia Pharmaceuticals Inc. (CA) | 2025-08-13 | — | — | EP | claimed |
| US-20250179121-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2025-06-05 | — | — | US | claimed |
| US-20250170069-A1 | NANOPREPARATION FOR JOINT ANALGESIA, AND PREPARATION METHOD AND USE THEREOF | XIANGYA HOSPITAL CENTRAL SOUTH UNIV (CN) | 2025-05-29 | — | — | US | claimed |
| WO-2025085674-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ULCERATIVE COLITIS | BACAINN THERAPEUTICS, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| US-12252556-B2 | Cyclosporine compositions and methods of use | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2025-03-18 | — | — | US | claimed |
| EP-0614354-A1 | USE OF SALICYLIC ACID FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY | RICHARDSON-VICKS, INC. (US) | 1994-09-14 | — | — | EP | claimed |
| US-5236906-A | Adrenocortical hormone and hyaluronic acid; skin diseases | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-08-17 | — | — | US | claimed |
| WO-1993010756-A1 | USE OF SALICYLIC ACID FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY | RICHARDSON-VICKS, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| WO-1993010755-A1 | COMPOSITIONS FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY | RICHARDSON-VICKS, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| US-4844902-A | Topically applicable formulations of gyrase inhibitors in combination with corticosteroids | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | claimed |
| EP-0241134-A1 | Pharmaceutical mixture comprising nedocromil or a salt thereof in combination with a bronchodilator | FISONS plc (GB) | 1987-10-14 | — | — | EP | claimed |
| EP-0068553-B1 | TOPICAL ANTIMICROBIAL ANTI-INFLAMMATORY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1985-11-21 | — | — | EP | claimed |
| US-4427670-A | CONTAINING CORTICOSTEROID, PHOSPHATIDE, AND BUTYLHYDROXYANISOLE, OR BUTYLHYDROXYTOLUENE | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1984-01-24 | — | — | US | claimed |
| EP-0068553-A1 | Topical antimicrobial anti-inflammatory compositions | THE PROCTER & GAMBLE COMPANY (US) | 1983-01-05 | — | — | EP | claimed |
| US-4343798-A | Topical antimicrobial anti-inflammatory compositions | THE PROCTER & GAMBLE COMPANY (US) | 1982-08-10 | — | — | US | claimed |